Vivace Therapeutics' Series B Round

Vivace Therapeutics raised a round of funding on May 18, 2017.

Vivace Therapeutics specializes in oncology-focused portfolio-based drug discovery and development. Vivace is initially concentrating on inhibitors of the Hippo-YAP signaling pathway, which plays a cr…

Articles about Vivace Therapeutics' Series B Round: